Nitrosamide carcinogens induce neural tumours with great ease in rats but not in mice. When mice of 4 inbred strains were treated neonatally with ENU (10-160 mg/kg body weight) some DBA and IF mice developed neural tumours (Searle and Jones, Nature, Lond., 1972, 240, 559) but tumours induced were predominantly of the liver (C57BL, DBA), lung (A) and thymus and/or spleen (A, DBA). Many mice had multiple primary tumours. The multipotential action of ENU in mice is relevant to the possibility that some human tumours might be caused by substances with a nitrosamide-like action. Though sensitive to carcinogenic polycyclic hydrocarbons, IF mice proved relatively resistant to carcinogenesis by ENU, recalling earlier findings with 4-nitroquinoline N-oxide (Searle and Spencer, Br. J. Cancer, 1966, 20, 877 One-of the factors responsible for the variations in the incidence of endocrine tumours among laboratory animals may be zearalenone, the oestrogenic secondary metabolite of Fusarium graminearum (Gibberella zeae) and of certain other fungi, which sometimes contaminate cereals.
Among wood constituents, which may contribute to the carcinogenic effects of certain wood shavings bedding (Schoental, Lab. Animals, 1973, 7, 47) Am. chem. Soc., 1953, 75, 235 A lymphocyte dependent cytotoxic antibody activity has been detected in the serum of 5 out of 38 melanoma patients. Three of them had been free of disease for at least a year and a half. The 2 others were patients submitted to a nonspecific immunotherapy by 2-4 dinitrochlorobenzene (DNCB). The cytotoxic mechanism induced by this antibody activity was found to be highly effective in terms of the number of melanocytes which can be killed by a given number of lymphoid cells and the antibody concentration needed to induce killing. These antibodies can increase the killing of allogeneic melanoma cells not only by sensitized lymphocytes (potentiation) but also by non-sensitized lymphocytes (" arming "). Arming and potentiating activities are usually but not always associated. In vitro studies showed that peritoneal macrophages (PM) taken from normal unsensitized mice, exert a strong nonspecific cytostatic effect on the Harding-Passey Melanoma (HPM) and on mouse mammary tumour (BALB/C syngeneic). This effect was assessed by cell counts and tritiated thymidine uptake. Non-adherent cells had no effect. No cytotoxicity was found according to the chromium release test.
A two-step cell culture system was used to assay separately PM lysates and PM supernatants. PM lysates, in most instances, exhibited a serum independent cytostatic effect. However, PM lysates from some young mice (C57 B1 and BDF1) had no effect when obtained from serum-free cultures, while they inhibited 75% of the thymidine uptake, when taken from PM cultures with as little as 0.5%0 foetal bovine serum. Further, it was found that sera from various species could produce this macrophage activation. The supernatant of 72 h cultured PM contained a cytostatic factor (CF) which could inhibit 50-75% of the thymidine incorporation in equal number of HPM cells. CF was found to be thermostable and dialysable.
These findings suggest that some normal serum components could substitute in vitro for the in vivo activation of PM.
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Macrophages from mice sensitized to one antigen become nonspecifically cytotoxic to tumour cells after meeting the same antigen again (Evans and Alexander, Nature, Lond., 1972, 236, 168) . This transformation was termed macrophage activation. Where a condition of chronic infection has become established, persistence of the infecting antigen can lead to the presence of activated macrophages (Hibbs, Lambert and Remmington, J. infect. Dis., 1971, 124, 587) . No activated macrophages could be demonstrated in the peritoneal cavities of mice that had been injected i.p. with B.C.G. 2 weeks previously. This may be a reflection of the fact that the strain of B.C.G. (Glaxo) that was used does not persist in large numbers in the peritoneal cavities of mice. Reintroduction of the antigen (as PPD) into the same site as the tumour cells protected against syngeneic tumour challenge with either lymphoma (L5178Y in DBA/2 mice) or fibrosarcoma (FS6 in C57B1 mice). Peritoneal exudate (PE) cells from B.C.G. sensitized mice could be made cytotoxic to fibrosarcoma cells by re-addition of the antigen. In a family of 5 girls, 3 of whom have Hodgkin's disease, pathogenetic possibilities were studied, i.e. HL-A typing, chromosomes, detailed blood group analysis, humoral antibody (immunoglobulins, serum protein electrophoresis), cell mediated immunity (PPD, DNCB, LTT and MLC), viral studies (Epstein-Barr, other herpesviruses, CMV) Australia antigen.
The major abnormality was a defect of cell mediated immunity detected in both parents and the 5 girls as evidenced by very poor in vitro lymphocyte blastogenesis with PHA in all 7. The fourth sister (recent infectious mononucleosis), and the mother, were anergic to PPD and DNCB while the father and fifth sister (recurrent herpes labialis) both had 4+ DNCB, reaction. In addition, the mother had an M band on serum protein electrophoresis.
Our findings suggest that a familial cell mediated immune depletion is providing a milieu wherein viral infection may manifest itself as Hodgkin's disease. One patient with malignant melanoma showed regression of more than 70 B.C.G. injected subcutaneous metastases: the rate at which new deposits developed declined and there was only minimal spread to internal organs. Intra-tumoral B.C.G. was followed by regression and eventual sloughing of approximately 90% of an extensive fungating tumour in a patient with local recurrence of breast cancer in the mastectomy scar. Local reaction to intratumoral B.C.G., without retardation in the progression of the disease, was observed in a patient with malignant melanoma while prolongation of survival was noted in another patient who had a large solitary lung metastasis. There was no detectable response to B.C.G. in the remaining 3 cases.
SOME ASPECTS OF THE USE
Pyrexia, lassitude and anorexia occurred as transient side-effects of B.C.G. therapy in
